,
your personalized virtual assistant to find clinical trials. Go head, 
Mario Sznol, MD
Yale Comprehensive Cancer CenterNew Haven, Connecticut - 06520 (203-785-2604) Yale University School of MedicineNew Haven, Connecticut - 06519 (203-974-7043) |
- CLINICAL TRIALS 3
- CONDITIONS9
- INTERVENTIONS3
- SINCE2008
A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
October 2008 - March 2011
A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1
September 2009 - February 2013
Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)
July 2009 - August 2014
Lung Neoplasms
Lymphoma
Lymphoma, Non-Hodgkin
Neoplasms
Carcinoma, Renal Cell
Carcinoma
Carcinoma, Non-Small-Cell Lung
Melanoma
Lymphoma, B-Cell
Bms-936558 (Mdx-1106)
Cdx-1401 In Combination With Resiquimod And/Or Poly-Iclc
Mdx-1203
